Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, March 24, 2015, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $380.00 to $19,195,500.00.

Highlighted Stocks Traded by Insiders:

Oxford Immunotec Global (OXFD) - FREE Research Report

Clarus Lifesciences I, L.P., who is 10% Owner at Oxford Immunotec Global, sold 53,415 shares at $14.49 on March 24, 2015. Following this transaction, the 10% Owner owned 2.4 million shares meaning that the stake was reduced by 2.2% with the 53,415-share transaction.

The shares most recently traded at $14.00, down $0.49, or 3.47% since the insider transaction.

The average volume for Oxford Immunotec Global has been 88,600 shares per day over the past 30 days. Oxford Immunotec Global has a market cap of $317.2 million and is part of the health care sector and drugs industry. Shares are up 4.04% year-to-date as of the close of trading on Tuesday.

Oxford Immunotec Global PLC, a diagnostics company, develops and commercializes proprietary tests for the management of immune-regulated conditions in the United States, Europe, Japan, and China. Currently, there are 4 analysts who rate Oxford Immunotec Global a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OXFD - FREE

TheStreet Quant Ratings rates Oxford Immunotec Global as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Oxford Immunotec Global Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Village Super Market (VLGEA) - FREE Research Report

Crystal Steven, who is Director at Village Super Market, sold 1,000 shares at $30.75 on March 24, 2015. Following this transaction, the Director owned 953,066 shares meaning that the stake was reduced by 0.1% with the 1,000-share transaction.

Judge David, who is Director at Village Super Market, sold 1,000 shares at $31.04 on March 24, 2015. Following this transaction, the Director owned 11,800 shares meaning that the stake was reduced by 7.81% with the 1,000-share transaction.

The shares most recently traded at $31.49, up $0.45, or 1.43% since the insider transaction. Historical insider transactions for Village Super Market go as follows:

  • 4-Week # shares sold: 56,238
  • 12-Week # shares sold: 84,392
  • 24-Week # shares sold: 177,882

The average volume for Village Super Market has been 16,700 shares per day over the past 30 days. Village Super Market has a market cap of $296.1 million and is part of the services sector and retail industry. Shares are up 13.99% year-to-date as of the close of trading on Tuesday.

Village Super Market, Inc., together with its subsidiaries, operates a chain of supermarkets in the United States. The stock currently has a dividend yield of 3.27%. The company has a P/E ratio of 21.5. Currently, there are no analysts who rate Village Super Market a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VLGEA - FREE

TheStreet Quant Ratings rates Village Super Market as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, compelling growth in net income, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Village Super Market Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Global Partners (GLP) - FREE Research Report

Global GP LLC, who is Shareholder at Global Partners, bought 44,800 shares at $37.84 on March 24, 2015. Following this transaction, the Shareholder owned 453,219 shares meaning that the stake was boosted by 10.97% with the 44,800-share transaction.

The shares most recently traded at $36.51, down $1.33, or 3.63% since the insider transaction. Historical insider transactions for Global Partners go as follows:

  • 4-Week # shares bought: 7,551
  • 12-Week # shares bought: 7,551
  • 24-Week # shares bought: 209,294

The average volume for Global Partners has been 92,700 shares per day over the past 30 days. Global Partners has a market cap of $1.2 billion and is part of the services sector and wholesale industry. Shares are up 10.64% year-to-date as of the close of trading on Tuesday.

Global Partners LP, a midstream logistics and marketing company, distributes gasoline, distillates, residual oil, renewable fuels, crude oil, natural gas, and propane to wholesalers, retailers, and commercial customers in the New England states and New York. The stock currently has a dividend yield of 6.96%. The company has a P/E ratio of 9.7. Currently, there are 2 analysts who rate Global Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GLP - FREE

TheStreet Quant Ratings rates Global Partners as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, good cash flow from operations, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Global Partners Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null